Opaleye Management Inc.'s Form 4 filing
TELA Bio, Inc. (TELA) · filed Jun 30, 2022
- Accession no.
- 0001493152-22-018273
- Filed
- Jun 30, 2022
- Trade date
- Jun 29-30, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $25.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2 | $6.99 | +$13.98 | 1,542,002 | Indirect | |
| Jun 30, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,998 | $7.00 | +$20,986 | 1,545,000 | Indirect | |
| Jun 30, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +567 | $7.00 | +$3,969 | 98,367 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.